Skip to content

Effect of Mediterranean and Hypolipemic Reduction Diet in Obese Patients

Effect of the Mediterranean Diet and Hypolipemic Reduction Diet in Combination With Exercise in Obese Croatian Population- 1-year Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02259244
Enrollment
124
Registered
2014-10-08
Start date
2008-10-31
Completion date
2013-10-31
Last updated
2014-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The purpose of this study is to evaluate the combined effect of physical activity and adherence to Mediterranean diet or Hypolipemic Reduction diet on parameters of oxidative stress in obese patients enrolled in the weight management reduction program.

Interventions

Sponsors

University Hospital Dubrava
CollaboratorOTHER
University of Zagreb
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* BMI ≥ 30 kg/m2

Exclusion criteria

* newly diagnosed diabetes, hypertension or cardiovascular disease * change in antihypertensive therapy and antidiabetic therapy in the period of 3 months prior to the commencement of the study * insulin therapy * alcohol consumption \>500 g of alcohol/week in the last year * pregnancy or breast feeding * use of drugs affecting weight control (eg. weight loss medication or systemic glucocorticoids)

Design outcomes

Primary

MeasureTime frame
Oxidative stressThe outcome measure is studied at baseline, 1 and 12 months

Secondary

MeasureTime frameDescription
Waist circumference (cm)The outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
Fasting glycemiaThe outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
Lipid profile (HLD, LDL, TC,)The outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
UrateThe outcome measure is studied at baseline, at 1 week, 1 month, 3, 6 and 12 months
Body weight (kg)The outcome measure is studied at baseline, 1 week, 1 month, 3, 6 and 12 months
Physical activity levelThe outcome measure is studied at baseline, at 1 month, 3, 6 and 12 monthsIPAQ-SF for record on physical activity during 7 last 7 days.
Quality of lifeThe outcome measure is studied at baseline, at 1 month, 3, 6 and 12 monthsSF-36 questionnaire
Dietary intakesThe outcome measure is studied at baseline, at 1 month, 3, 6 and 12 monthsFood Frequency Questionnaire 7-day food diary
Blood pressure (mmHg)The outcome measure is studied at baseline, at 1 week, 1 month, 3, 6 and 12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026